Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
16.68
Dollar change
-1.14
Percentage change
-6.40
%
IndexNDX, S&P 500 P/E- EPS (ttm)-7.00 Insider Own17.51% Shs Outstand863.67M Perf Week-9.10%
Market Cap14.39B Forward P/E5.28 EPS next Y3.16 Insider Trans0.01% Shs Float711.66M Perf Month-8.45%
Income-6037.00M PEG- EPS next Q0.72 Inst Own59.17% Short Float5.64% Perf Quarter-23.31%
Sales144.60B P/S0.10 EPS this Y-19.01% Inst Trans-0.06% Short Ratio3.46 Perf Half Y-21.39%
Book/sh15.63 P/B1.07 EPS next Y-2.01% ROA-6.54% Short Interest40.16M Perf Year-46.68%
Cash/sh0.77 P/C21.54 EPS next 5Y-7.67% ROE-34.82% 52W Range17.12 - 32.89 Perf YTD-36.12%
Dividend Est.1.53 (9.15%) P/FCF- EPS past 5Y- ROI-13.79% 52W High-49.29% Beta0.77
Dividend TTM1.46 (8.75%) Quick Ratio0.32 Sales past 5Y1.35% Gross Margin16.90% 52W Low-2.57% ATR (14)0.59
Dividend Ex-DateMay 20, 2024 Current Ratio0.66 EPS Y/Y TTM-92.32% Oper. Margin0.60% RSI (14)36.17 Volatility3.81% 2.90%
Employees331000 Debt/Eq2.57 Sales Y/Y TTM8.48% Profit Margin-4.18% Recom3.05 Target Price22.48
Option/ShortYes / Yes LT Debt/Eq2.25 EPS Q/Q-941.30% Payout- Rel Volume2.18 Prev Close17.82
Sales Surprise3.32% EPS Surprise46.57% Sales Q/Q6.28% EarningsMar 28 BMO Avg Volume11.60M Price16.68
SMA20-5.91% SMA50-11.44% SMA200-24.16% Trades Volume25,075,352 Change-6.40%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Today 07:00AM
May-21-24 04:50PM
05:30AM
05:21AM
May-20-24 05:50PM
09:00AM Loading…
09:00AM
May-19-24 11:10AM
06:51AM
May-18-24 09:21AM
May-16-24 04:30PM
05:15AM
May-15-24 09:47AM
09:01AM
08:00AM
May-14-24 05:50PM
11:00AM Loading…
11:00AM
09:30AM
06:08AM
May-13-24 06:34PM
05:56PM
05:23PM
04:36PM
04:01PM
01:49PM
01:46PM
01:35PM
12:31PM
12:15PM
11:42AM
11:05AM
10:22AM Loading…
10:22AM
09:59AM
May-11-24 03:55AM
May-10-24 09:15AM
May-09-24 10:37AM
09:15AM
May-08-24 05:50PM
04:30PM
09:45AM
May-07-24 11:03AM
09:00AM
06:49AM
May-06-24 04:49PM
03:42PM
May-03-24 04:21PM
05:08AM
04:41AM
May-02-24 05:50PM
01:00PM
11:45AM
10:10AM
04:00AM
May-01-24 05:30PM
03:42PM
01:16PM
12:38PM
02:39AM
Apr-30-24 04:20PM
04:01PM
08:30AM
08:06AM
06:00AM
Apr-27-24 03:00AM
Apr-26-24 02:30PM
11:39AM
09:00AM
07:35AM
Apr-25-24 07:41PM
01:53PM
10:10AM
12:01AM
Apr-24-24 11:55PM
05:09PM
11:44AM
09:00AM
Apr-22-24 08:57AM
Apr-20-24 09:16AM
Apr-18-24 12:00PM
10:56AM
Apr-17-24 09:00AM
Apr-16-24 10:45AM
05:21AM
Apr-15-24 06:31PM
08:00AM
Apr-12-24 12:58PM
12:56PM
Apr-11-24 05:34AM
Apr-10-24 04:42PM
09:53AM
07:45AM
Apr-09-24 03:38PM
10:45AM
Apr-07-24 05:35AM
03:00AM
Apr-04-24 01:44PM
09:00AM
08:40AM
Apr-03-24 01:48PM
11:34AM
08:45AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bhandari Inderpal SDirectorApr 11 '24Buy18.053,00054,1503,000Apr 15 05:45 PM
Mahajan ManmohanEVP and Global CFOApr 02 '24Buy19.386,000116,280166,969Apr 02 06:40 PM
Walgreens Boots Alliance, Inc.10% OwnerFeb 07 '24Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29 '24Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16 '24Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05 '24Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10 '23Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09 '23Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03 '23Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30 '23Buy28.425,172146,98459,050Jul 05 06:57 PM
Walgreens Boots Alliance, Inc.10% OwnerJun 15 '23Sale181.17275,98450,000,02133,090,404Jun 20 06:03 AM